Dual-color tumor-host imaging models
双色肿瘤宿主成像模型
基本信息
- 批准号:7109037
- 负责人:
- 金额:$ 37.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This Phase II application will further develop dual-color imageable tumor-host-interaction nude mouse models, developed in the Phase I application, to be used in Phase III to discover and evaluate new effective agents for stromal therapy, including angiogenesis. The host models are the ubiquitously-expressing green fluorescent protein (GFP)-nude mouse with GFP under control of the beta-actin promoter (BAD-GFP) (Yang, M., et al., Proc. Natl. Acad. Sci. USA 98, 2616-2621, 2001 and Yang, M., et al., Cancer Research, 64, 8651- 8656, 2004) and the nestin-driven-GFP (ND-GFP) nude mouse in which nascent blood vessels are labeled with GFP (Amoh, Y., et al., Cancer Res. 65, 5352-5357, 2005). All of the tissues of the BAD-GFP mice, with the exception of erythrocytes and hair, fluoresce green under blue excitation light. In ND-GFP mice, nascent blood vessels express GFP. Transplanted red fluorescent protein (RFP)-expressing tumors and GFP- expressing stromal cells can be clearly imaged simultaneously in the BAD-GFP models. Dual-color orthotopic models of human breast, colon and prostate cancer will be developed in both the BAD-GFP and ND-GFP models to image tumor-host interaction in both primary and resulting metastases. Dual-color imaging enables resolution of the tumor and the host tissues down to the single cell level. All tumor- interacting host stromal cells can be uniquely imaged in the BAD-GFP model including live mice. The stromal cells are targets for new stromal therapy. Nascent tumor angiogenesis can be uniquely imaged in the ND- GFP model. Nascent angiogenesis is a potentially critical target for antitumor and antimetastatic therapy and is uniquely visualized in human tumors in the live ND-GFP nude mouse. These color-coded nude mouse models of human cancer will be used to visualize new targets which should greatly enhance the discovery of stromal-targeting and anti-angiogenesis drugs. The specific aims include: (1) Development of dual-color tumor-host models with the BAD-GFP nude mouse with orthotopic RFP-expressing human tumors for discovery of stroma-targeted therapeutic agents. (2) Development of dual-color tumor-host models with the ND-GFP nude mouse with orthotopic RFP-expressing tumor models for discovery of specific agents which target nascent angiogenesis. These models have significant commercial potential for discovery and development of stroma-targeted and anti-angiogenesis drugs.
描述(由申请人提供):该II期申请将进一步开发在I期申请中开发的双色可成像肿瘤-宿主相互作用裸鼠模型,用于III期,以发现和评估用于基质治疗(包括血管生成)的新的有效药物。宿主模型是具有在β-肌动蛋白启动子控制下的GFP的遍在表达绿色荧光蛋白(GFP)-裸鼠(BAD-GFP)(Yang,M.,例如,Proc. Natl. Acad. Sci. USA 98,2616-2621,2001和Yang,M.,例如,Cancer Research,64,8651- 8656,2004)和巢蛋白驱动的GFP(ND-GFP)裸鼠,其中新生血管用GFP标记(Amoh,Y.,例如,Cancer Res.65,5352-5357,2005)。除了红细胞和毛发外,BAD-GFP小鼠的所有组织在蓝色激发光下发出绿色荧光。在ND-GFP小鼠中,新生血管表达GFP。在BAD-GFP模型中,移植的表达红色荧光蛋白(RFP)的肿瘤和表达GFP的基质细胞可以同时清晰成像。将在BAD-GFP和ND-GFP模型中开发人乳腺癌、结肠癌和前列腺癌的双色原位模型,以成像原发和产生的转移中的肿瘤-宿主相互作用。双色成像使肿瘤和宿主组织的分辨率下降到单细胞水平。所有与肿瘤相互作用的宿主基质细胞都可以在包括活小鼠的BAD-GFP模型中独特地成像。基质细胞是新的基质治疗的靶点。新生的肿瘤血管生成可以在ND-GFP模型中独特地成像。新生血管生成是抗肿瘤和抗转移治疗的潜在关键靶点,并且在活体ND-GFP裸小鼠的人类肿瘤中独特地显现出来。这些彩色编码的人类癌症裸鼠模型将被用于可视化新的靶点,这将极大地促进基质靶向和抗血管生成药物的发现。具体目标包括:(1)开发具有原位表达RFP的人肿瘤的BAD-GFP裸鼠的双色肿瘤宿主模型,用于发现基质靶向治疗剂。(2)用ND-GFP裸鼠和原位RFP表达肿瘤模型开发双色肿瘤宿主模型,用于发现靶向新生血管生成的特异性药物。这些模型对于发现和开发基质靶向和抗血管生成药物具有显著的商业潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MENG YANG其他文献
MENG YANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MENG YANG', 18)}}的其他基金
Pancreatic-Cancer Imageable Patient-Derived Orthotopic Xenografts (iPDOX)
胰腺癌可成像患者来源的原位异种移植物 (iPDOX)
- 批准号:
8780448 - 财政年份:2014
- 资助金额:
$ 37.58万 - 项目类别:
Orthotopic models of tumor angiogenesis and blood flow
肿瘤血管生成和血流的原位模型
- 批准号:
7160990 - 财政年份:2003
- 资助金额:
$ 37.58万 - 项目类别:
Orthotopic models of tumor angiogenesis and blood flow
肿瘤血管生成和血流的原位模型
- 批准号:
7292746 - 财政年份:2003
- 资助金额:
$ 37.58万 - 项目类别:
Orthotopic models of tumor angiogenesis and blood flow
肿瘤血管生成和血流的原位模型
- 批准号:
6582762 - 财政年份:2003
- 资助金额:
$ 37.58万 - 项目类别:
GFP IMAGING FOR IN VIVO HIGH-THROUGHPUT DRUG SCREENING
用于体内高通量药物筛选的 GFP 成像
- 批准号:
6446853 - 财政年份:2001
- 资助金额:
$ 37.58万 - 项目类别:
相似海外基金
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056554 - 财政年份:1990
- 资助金额:
$ 37.58万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056556 - 财政年份:1989
- 资助金额:
$ 37.58万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056555 - 财政年份:1988
- 资助金额:
$ 37.58万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056553 - 财政年份:1987
- 资助金额:
$ 37.58万 - 项目类别:
The Athymic Mouse As a Model For the Study of Keloids
无胸腺小鼠作为瘢痕疙瘩研究的模型
- 批准号:
7816691 - 财政年份:1978
- 资助金额:
$ 37.58万 - 项目类别:
Standard Grant